Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
nasal decongestant
|
| gptkbp:activeIngredient |
oxymetazoline hydrochloride
|
| gptkbp:availableStrength |
0.05% oxymetazoline
|
| gptkbp:brand |
oxymetazoline nasal spray
|
| gptkbp:contraindication |
narrow-angle glaucoma
children under 6 years hypersensitivity to oxymetazoline |
| gptkbp:countryOfOperation |
gptkb:Canada
gptkb:United_States various countries |
| gptkbp:duration |
up to 12 hours
not more than 3 days |
| gptkbp:effect |
vasoconstriction of nasal blood vessels
|
| gptkbp:form |
nasal spray
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bayer Afrin (nasal spray)
|
| gptkbp:indication |
nasal congestion
sinus congestion |
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:mechanismOfAction |
alpha-adrenergic agonist
|
| gptkbp:onset |
within minutes
|
| gptkbp:OTC |
yes
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
over-the-counter
|
| gptkbp:routeOfAdministration |
intranasal
|
| gptkbp:sideEffect |
sneezing
nasal dryness rebound congestion |
| gptkbp:storage |
store at room temperature
|
| gptkbp:bfsParent |
gptkb:Bayer
|
| gptkbp:bfsLayer |
5
|